John S Parks Selected Research

Pre-beta High-Density Lipoproteins

6/2012	Hepatic ABC transporters and triglyceride metabolism.
5/2012	Hepatic ABCA1 and VLDL triglyceride production.
4/2010	A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John S Parks Research Topics

Disease

26	Atherosclerosis 01/2022 - 02/2002
23	Inflammation (Inflammations) 01/2021 - 02/2008
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2007
7	Insulin Resistance 01/2019 - 09/2008
7	Tangier Disease 10/2017 - 05/2005
6	Obesity 01/2021 - 09/2008
5	Body Weight (Weight, Body) 01/2022 - 12/2014
5	Hepatocellular Carcinoma (Hepatoma) 10/2017 - 04/2010
5	Atherosclerotic Plaque (Atheroma) 03/2016 - 09/2007
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2012 - 09/2008
4	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 05/2009 - 02/2002
3	Neoplasms (Cancer) 10/2020 - 09/2017
3	Fatty Liver 01/2020 - 06/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2015 - 02/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 04/2017
2	Neoplasm Metastasis (Metastasis) 10/2020 - 09/2017
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 02/2016
2	Hypertrophy 02/2016 - 09/2014
2	Infections 11/2012 - 06/2010
2	Coronary Disease (Coronary Heart Disease) 08/2012 - 01/2004
2	Diabetic Nephropathies (Diabetic Nephropathy) 11/2011 - 12/2010
2	Hypersensitivity (Allergy) 09/2008 - 02/2008
1	Dysbiosis 01/2021
1	Sepsis (Septicemia) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Heart Failure 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Albuminuria 01/2019
1	Weight Loss (Weight Reduction) 03/2018
1	Disease Progression 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Weight Gain 01/2018
1	Hypopituitarism (Sheehan's Syndrome) 01/2018
1	Carcinogenesis 09/2017

Drug/Important Bio-Agent (IBA)

31	CholesterolIBA 01/2022 - 02/2002
26	LipidsIBA 01/2021 - 11/2004
12	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2018 - 08/2006
11	LDL Receptors (LDL Receptor)IBA 01/2021 - 02/2002
10	Triglycerides (Triacylglycerol)IBA 03/2018 - 04/2010
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2009
8	HDL LipoproteinsIBA 09/2017 - 08/2006
8	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2017 - 05/2005
8	Lipoproteins (Lipoprotein)IBA 09/2014 - 02/2002
7	ApolipoproteinsIBA 09/2014 - 02/2002
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 02/2008
5	oxidized low density lipoproteinIBA 09/2014 - 06/2005
4	EnzymesIBA 01/2020 - 01/2011
4	Insulin (Novolin)FDA Link 03/2018 - 02/2012
4	Apolipoproteins E (ApoE)IBA 05/2009 - 02/2002
3	Apolipoproteins B (ApoB)IBA 10/2017 - 02/2002
3	HDL CholesterolIBA 09/2017 - 04/2006
3	Fish OilsIBA 09/2012 - 01/2010
3	Pre-beta High-Density LipoproteinsIBA 06/2012 - 04/2010
2	Liver X ReceptorsIBA 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2017
2	SterolsIBA 09/2017 - 07/2008
2	LipopolysaccharidesIBA 01/2017 - 06/2010
2	VLDL CholesterolIBA 01/2017 - 06/2015
2	Dietary CholesterolIBA 02/2016 - 09/2014
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 12/2014
2	Apolipoprotein L1IBA 02/2015 - 11/2011
2	VLDL LipoproteinsIBA 10/2013 - 05/2013
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2013 - 02/2002
2	Acetyl-CoA CarboxylaseIBA 01/2013 - 01/2011
2	ATP Binding Cassette Transporter 1IBA 11/2012 - 05/2005
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2012 - 02/2008
2	Palm OilIBA 09/2012 - 01/2012
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 05/2012 - 04/2010
2	Phospholipids (Phosphatides)FDA LinkGeneric 05/2012 - 06/2005
2	Conditioned Culture MediaIBA 04/2012 - 04/2010
2	Messenger RNA (mRNA)IBA 01/2011 - 11/2009
2	Oleic Acid (Oleate)IBA 04/2010 - 09/2008
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Tricarboxylic AcidsIBA 01/2021
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	QuercetinIBA 01/2021
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 10/2020
1	AMP-Activated Protein KinasesIBA 10/2020
1	Mineralocorticoid Receptor AntagonistsIBA 01/2020
1	Biological ProductsIBA 01/2020
1	lysophosphatidic acidIBA 01/2020
1	GlycosphingolipidsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Apolipoproteins MIBA 01/2020
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	Enoyl-CoA HydrataseIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 03/2018
1	Nicotine FDA Link 03/2018
1	Fatty Acid DesaturasesIBA 01/2018
1	Arachidonic Acid (Vitamin F)IBA 01/2018
1	Two-Pore ChannelsIBA 01/2018
1	Eicosapentaenoic AcidIBA 01/2018
1	Growth Hormone (Somatotropin)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018

Therapy/Procedure

1	Ligation 01/2021
1	Punctures 01/2021